Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9

Jame Abraham, André Robidoux, Antoinette R. Tan, Steven Limentani, Keren Sturtz, I. Shalaby, Hope G. Alcorn, Marc Buyse, Norman Wolmark, Samuel A. Jacobs

Breast Cancer Research and Treatment · 2015 · 24 citations · 19 references

Concepts

References

19